Virum, Denmark

Hans Peter Heldt-Hansen

This inventor holds 33 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Enzyme Technology. Top assignees: Novo Nordisk A/s, Novozymes A/s, Gist-Brocades B.v.. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Peter Heldt-Hansen. Retrieved from https://idiyas.com/inventor/hans-peter-heldt-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 87.9

 

 

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 166(Granted Patents)


Location History:

  • Copenhagen, DK (2000)
  • Virum, DK (1996 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Enzyme Technology
Xylanase
Proteases
Dairy Products
Acidified Milk
Heat-Treated Products
Polypeptides
Polynucleotides
Rhamnogalacturonase
Pectin Lyase
Asparaginases
Gel Formation
33 patents (USPTO):Explore Patents

Sure, I'd be happy to help you with that. Here's the article about inventor Hans Peter Heldt-Hansen:

Title: Hans Peter Heldt-Hansen: A Trailblazer in Innovation

Introduction:

In the realm of inventors, Hans Peter Heldt-Hansen stands out as a true trailblazer, known for his relentless pursuit of innovation and commitment to pushing the boundaries of what is possible. With an impressive portfolio of 32 patents to his name, he has made significant contributions to the world of inventions.

Latest Patents:

Hans Peter Heldt-Hansen's latest patents showcase his expertise and creativity in the field of biotechnology. One of his recent inventions is the "Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidase," which revolutionizes the process of protein hydrolysis using specific enzymes. Additionally, he has developed a "Polynucleotide encoding polypeptide having carboxypeptidase activity," which further enhances the production of protein hydrolysates.

Career Highlights:

Having worked with reputable companies such as Novo Nordisk A/S and Novozymes A/S, Hans Peter Heldt-Hansen has proven his prowess in the industry. His innovative spirit and dedication to advancing biotechnological processes have earned him a reputation as a visionary inventor.

Collaborations:

Throughout his career, Hans Peter Heldt-Hansen has collaborated with esteemed colleagues such as Stephan Christgau and Lene Nonboe Andersen. Together, they have contributed to groundbreaking research and development initiatives, shaping the future of biotechnology.

Conclusion:

In conclusion, Hans Peter Heldt-Hansen's exceptional track record of innovation, coupled with his collaborations and career highlights, solidifies his position as a trailblazer in the world of inventions. His unwavering commitment to pushing boundaries and exploring new possibilities continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…